Science Corporation implants its vision-restoring chip in its first Stargardt disease patient

Max Hodak, the former president and co-founder of Neuralink, detailed on stage at TechCrunch Disrupt how his company's work with PRIMA is part of its path toward a novel brain-computer interface (BCI). Disrupt 2026 has officially begun. Grab your pass now to be at the center of the startup epicenter. REGISTER NOW

Detailed Chronological Breakdown

Max Hodak, the former president and co-founder of Neuralink, detailed on stage at TechCrunch Disrupt how his company's work with PRIMA is part of its path toward a novel brain-computer interface (BCI).

Disrupt 2026 has officially begun. Grab your pass now to be at the center of the startup epicenter. REGISTER NOW

Disrupt doors open Oct. 13. Get your pass and bring someone with you at 50% off. REGISTER NOW.

Key Verified Facts

• •Max Hodak, the former president and co-founder of Neuralink, detailed on stage at TechCrunch Disrupt how his company's work with PRIMA is part of its path toward a novel brain-computer interface (BCI).
• •Disrupt 2026 has officially begun. Grab your pass now to be at the center of the startup epicenter. REGISTER NOW
• •Disrupt doors open Oct. 13. Get your pass and bring someone with you at 50% off. REGISTER NOW.

Verified Factual Context

This factual report is compiled from verified documentation, official agency disclosures, and confirmed public reporting. Editorial verification standards ensure only confirmed factual claims from TechCrunch AI & Enterprise are presented without speculation.